Table 2 Association of trans fatty acids (elaidic acid, palmitelaidic acid, and linoelaidic acid) with odds of prostate cancer case status
From: Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men
Ghanaian | African American | European American | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
median | median | median | ||||||||||
concentration | Control | Case | Multivariablea | concentration | Control | Case | Multivariablea | concentration | Control | Case | Multivariablea | |
(µg/ml) | N | N | OR (95% CI) | (µg/ml) | N | N | OR (95% CI) | (µg/ml) | N | N | OR (95% CI) | |
Elaidic acid | ||||||||||||
Low | 2.89 | 219 | 143 | Ref. | 9.93 | 154 | 99 | Ref. | 10.46 | 128 | 70 | Ref. |
Intermediate | 4.11 | 219 | 169 | 1.55 (1.03, 2.35) | 17.06 | 122 | 128 | 1.83 (1.25, 2.68) | 17.67 | 160 | 134 | 1.38 (0.94, 2.03) |
High | 6.54 | 220 | 273 | 1.92 (1.30, 2.84) | 34.41 | 105 | 180 | 2.98 (2.04, 4.34) | 33.25 | 176 | 235 | 2.17 (1.51, 3.12) |
Ptrend | 0.001 | 1.80E-08 | 1.20E-05 | |||||||||
Palmitelaidic acid | ||||||||||||
Low | 1.73 | 220 | 105 | Ref. | 2.86 | 172 | 140 | Ref. | 3.08 | 109 | 75 | Ref. |
Intermediate | 2.71 | 218 | 178 | 1.51 (0.98, 2.32) | 4.44 | 130 | 135 | 1.43 (1.00, 2.05) | 4.57 | 153 | 139 | 1.31 (0.89, 1.93) |
High | 4.25 | 220 | 302 | 2.26 (1.50, 3.39) | 6.76 | 79 | 132 | 2.55 (1.73, 3.77) | 7.15 | 202 | 22 | 1.49 (1.04, 2.14) |
Ptrend | 6.90E-05 | 3.10E-06 | 0.035 | |||||||||
Linoelaidic acid | ||||||||||||
Low | 3.50 | 219 | 153 | Ref. | 5.91 | 178 | 125 | Ref. | 6.11 | 104 | 61 | Ref. |
Intermediate | 4.72 | 220 | 148 | 0.97 (0.64, 1.46) | 8.80 | 117 | 158 | 2.17 (1.52, 3.10) | 9.06 | 165 | 129 | 1.26 (0.84, 1.88) |
High | 6.70 | 219 | 284 | 1.52 (1.03, 2.23) | 14.01 | 86 | 124 | 2.34 (1.59, 3.45) | 14.81 | 195 | 249 | 1.93 (1.32, 2.82) |
Ptrend | 0.025 | 7.10E-06 | 1.70E-04 |